Due to their icosahedral structure with a high density of B- and T-cell epitopes, hepatitis B virus (HBV) core (HBc) particles are used as components of novel anti-HBV vaccines. Previous experiments demonstrated that C-terminally truncated HBV core (HBcΔ) proteins, which lack the polyarginine domain, were produced more efficiently in E. coli compared with full-length HBc. We have established a tryptophan operon promoter-directed high-level production system of 145 amino acid HBcΔ (HBc145); however, the level of HBc145 synthesis varied among individual subclones. Further investigation revealed that the subclones exhibiting higher HBc145 synthesis also demonstrated plasmid dimerization, leading to HBc145 yields that were 60 ∼ 65% (mg/g) or 25 ∼ 30% (mg/L) higher compared to clones containing a monomeric plasmid. These data were confirmed in at least three independent expression and purification events. Although plasmid dimerization is generally considered to inhibit plasmid stability in a growing cell population, it was found to have a positive effect on HBc145 synthesis and production in both Trp-deficient and Trp-rich media. This finding should be considered when planning large-scale production of HBc145.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Brown, A. L., M. J. Francis, G. Z. Hastings, N. R. Parry, P. V. Barnett, D. J. Rowlands, and B. E. Clarke (1991) Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine 9: 595–601.
Schödel, F., A. M. Moriarty, D. L. Peterson, J. A. Zheng, J. L. Hughes, H. Will, D. J. Leturcq, J. S. McGee, and D. R. Milich (1992) The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J. Virol. 66: 106–114.
Borisova, G., B. Arya, A. Dislers, O. Borschukova, V. Tsibinogin, D. Skrastina, M. A. Eldarov, P. Pumpens, K. G. Skryabin, and E. Grens (1993) Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen. J. Virol. 67: 3696–3701.
Koletzki, D., S. S. Biel, H. Meisel, E. Nugel, H. R. Gelderblom, D. H. Krüger, and R. Ulrich (1999) HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. Biol. Chem. 380: 325–333.
Pumpens, P., R. Ulrich, K. Sasnauskas, A. Kazaks, V. Ose, and E. Grens (2009) Construction of novel vaccines on the basis of the virus-like particles: Hepatitis B virus proteins as vaccine carriers. pp. 205–248. In: Y. Khudyakov (ed.). Medicinal Protein Engineering. CRC Press, Taylor & Francis Group, Boca Raton London, NY, USA.
Whitacre, D. C., B. O. Lee, and D. R. Milich (2009) Use of hepadnavirus core proteins as vaccine platforms. Expert. Rev. Vac. 8: 1565–1573.
Oliveira, G. A., K. Wetzel, J. M. Calvo-Calle, R. Nussenzweig, A. Schmidt, A. Birkett, F. Dubovsky, E. Tierney, C. H. Gleiter, G. Boehmer, A. J. Luty, M. Ramharter, G. B. Thornton, P. G. Kremsner, and E. H. Nardin (2005) Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant montanide ISA 720 in phase I trial. Infect. Immun. 73: 3587–3597.
De Filette, M., W. M. Jou, A. Birkett, K. Lyons, B. Schultz, A. Tonkyro, S. Resch, and W. Fiers (2005) Universal influenza A vaccine: Optimization of M2-based constructs. Virol. 337: 149–161.
Nassal, M., C. Skamel, M. Vogel, P. A. Kratz, T. Stehle, R. Wallich, and M. M. Simon (2008) Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: New particulate lyme disease vaccines. Int. J. Med. Microbiol. 298: 135–142.
Borisova, G. P., I. V. Kalis, P. M. Pushko, V. V. Tsibinogin, V. I. Loseva, V. P. Ose, E. I. Stankevich, A. I. Dreimane, D. I. Sniker, E. E. Grinstein, P. P. Pumpen, and E. J. Gren (1988) Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-assembly. Dokl. Akad. Nauk SSSR 298: 1474–1478.
Gallina, A., F. Bonelli, L. Zentilin, G. Rindi, M. Muttini, and G. Milanesi (1989) A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J. Virol. 63: 4645–4652.
Wingfield, P. T., S. J. Stahl, R. W. Williams, and A. C. Steven (1995) Hepatitis core antigen produced in Escherichia coli: Subunit composition, conformational analysis, and in vitro capsid assembly. Biochem. 34: 4919–4932.
Cooper, A. and Y. Shaul (2005) Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells. Biochem. Biophys. Res. Commun. 327: 1094–1099.
Crowther, R. A., N. A. Kiselev, B. Böttcher, J. A. Berriman, G. P. Borisova, V. Ose, and P. Pumpens (1994) Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77: 943–950.
Wynne, S. A., R. A. Crowther, and A. G. W. Leslie (1999) The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3: 771–780.
Leonhartsberg, S. (2006) E. coli expression system efficiently secretes recombinant proteins into culture broth. BioProc. Internat. 4: 64–66.
Schmidt, F. R. (2004) Recombinant expression systems in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 65: 363–372.
Bass, S. H. and D. G. Yansura (2000) Application of the E. coli trp promoter. Mol. Biotechnol. 16: 253–260.
Borisova, G. P., I. Berzins, P. M. Pushko, P. Pumpen, E. J. Gren, V. V. Tsibinogin, V. Loseva, V. Ose, R. Ulrich, H. Siakkou, and H. A. Rosenthal (1989) Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface. FEBS Lett. 259: 121–124.
Borisova, G., O. Borschukova, D. Skrastina, A. Dislers, V. Ose, P. Pumpens, and E. Grens (1999) Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol. Chem. 380: 315–324.
Kazaks, A., G. Borisova, S. Cvetkova, L. Kovalevska, V. Ose, I. Sominskaya, P. Pumpens, D. Skrastina, and A. Dislers (2004) Mosaic hepatitis B core particles presenting complete preS sequence of viral envelope on their surface. J. Gen. Virol. 85: 2665–2670.
Dislers, A., I. Sominska, A. Kazaks, I. Petrovskis, and I. Zarina (2008) Expression system for producing recombinant virus-like particles. Patent LV 13587 (B)IPC1-7: A61K39/29; C12N15/71.
Kazaks, A., R. Balmaks, T. Voronkova, V. Ose, and P. Pumpens (2008) Melanoma vaccine candidates from chimeric hepatitis B core virus-like particles carrying a tumor-associated MAGE-3 epitope. Biotechnol. J. 3: 1429–1436.
Smith, G. (1988) Homologous recombination in prokaryotes. Microbiol. Rev. 52: 1–28.
Summers, D. K. and D. J. Sherratt (1984) Multimerization of high copy number plasmids causes instability: CoIE1 encodes a determinant essential for plasmid monomerization and stability. Cell 36: 1097–1103.
Summers, D. K., C. W. H. Beton, and H. L. Withers (1993) Multicopy plasmid instability: the dimer catastrophe hypothesis. Mol. Microbiol. 8: 1031–1038.
Field, C. M. and D. K. Summers (2011) Multicopy plasmid stability: Revisiting the dimer catastrophe. J. Theor. Biol. 291: 119–127.
Mazin, A. V., T. V. Timchenko, M. K. Saparbaev, and O. M. Mazina (1996) Dimerization of plasmid DNA accelerates selection for antibiotic resistance. Mol. Microbiol. 20: 101–108.
Pumpen, P. P., A. V. Dishler, T. M. Kozlovskaia, V. V. Bychko, E. I. Gren, M. B. Rivkina, A. P. Grinberg, and R. A. Kukaine (1981) Cloning of hepatitis B virus DNA in Escherichia coli. Dokl. Akad. Nauk. SSSR 260: 1022–1024.
Bichko, V., P. Pushko, D. Dreilina, P. Pumpen, and E. Gren (1985) Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett. 185: 208–212.
Soberon, X., L. Covarrubias, and F. Bolivar (1980) Construction and characterization of new cloning vehicles, IV. Deletion derivatives of pBR322 and pBR325. Gene 9: 287–305.
Pushko, P., M. Sallberg, G. Borisova, U. Ruden, V. Bichko, B. Wahren, P. Pumpens, and L. Magnius (1994) Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virol. 202: 912–920.
About this article
Cite this article
Berza, I., Dishlers, A., Petrovskis, I. et al. Plasmid dimerization increases the production of hepatitis B core particles in E. coli . Biotechnol Bioproc E 18, 850–857 (2013). https://doi.org/10.1007/s12257-013-0188-5
- recombinant hepatitis B virus core protein
- virus-like particles
- plasmid monomers
- plasmid dimers